HCA
Based in TN
🤖
AI Overview
With $3.2M in lobbying spend across 30 quarterly filings, HCA is a significant lobbying presence. They deploy 12 individual lobbyists
$3.2M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
12
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $390K |
| 2019 | $390K |
| 2020 | $520K |
| 2021 | $520K |
| 2022 | $400K |
| 2023 | $320K |
| 2024 | $320K |
| 2025 | $360K |
Lobbying Firms
THE SMITH-FREE GROUP, LLC
What They Lobby For
- Monitored implementation of the Affordable Care Act
- HR 1156 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) S 1133 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) HR 277 American Health Care Reform Act of 2017 (all sections of full text) Discussions seeking guidance to minimize supply chain shortages for areas hit by natural disasters Monitored S 297 Increasing Competition in Pharmaceuticals Act Monitored HR 749 Lower Drug Costs through Competition Act Monitored HR 208 Ensuring Health Care Opportunities Act Monitored S 1115 Making Pharmaceutical Markets More Competitive Act Monitored HR 2562 Making Pharmaceutical Markets More Competitive Act Monitored S 191 Patient Freedom Act of 2017 Monitored S 761 Health Care Options Act of 2017 Monitored HR 1933 Health Care Options Act of 2017 Monitored HR 1628 American Health Care Act of 2017 Monitored Bipartisan Health Care Stabilization Act 2017 (proposed Alexander-Murray legislation) Monitored The Lower Premiums Through Reinsurance Act of 2017 (proposed Collins-Nelson legislation) Monitored S 2312 Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act Monitored politically appointed Senate-confirmed positions Monitored PL 115-141 Consolidated Appropriations Act, 2018 Monitored HR 4191 HHS Cybersecurity Modernization Act Monitored HR 4710 340B PAUSE Act Monitored H.R.4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes
- Discussions pertaining to budget sequestration limits on Medicare spending Discussions involving nominations to federally authorized commissions Discussions pertinent to the proposed reduction in the amount of Medicare bad debt payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital Monitored HR 1130 Fair Medicare Hospital Payments Act of 2017 Monitored S 41 Medicare Prescription Drug Price Negotiation Act of 2017 Monitored HR 242 Medicare Prescription Drug Price Negotiation Act of 2017
- Monitored implementation of PL 115-97 Tax Cuts and Jobs Act
- Discussions related to federal natural disaster assistance for hospitals and The Stafford Act Monitored discussions pertaining to the President's FY2019 HHS Budget
- HR 1156 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) S 1133 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) Monitored HR 277 American Health Care Reform Act of 2017 Monitored S 297 Increasing Competition in Pharmaceuticals Act Monitored HR 749 Lower Drug Costs through Competition Act Monitored HR 208 Ensuring Health Care Opportunities Act Monitored S 1115 Making Pharmaceutical Markets More Competitive Act Monitored HR 2562 Making Pharmaceutical Markets More Competitive Act Monitored S 191 Patient Freedom Act of 2017 Monitored S 761 Health Care Options Act of 2017 Monitored HR 1933 Health Care Options Act of 2017 Monitored HR 1628 American Health Care Act of 2017 Monitored Bipartisan Health Care Stabilization Act 2017 (proposed Alexander-Murray legislation) Monitored S 1835 The Lower Premiums Through Reinsurance Act of 2017 Monitored S 2312 Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act Monitored politically appointed Senate-confirmed positions Monitored S 3158 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 Monitored HR 4191 HHS Cybersecurity Modernization Act Monitored HR 4710 340B PAUSE Act Monitored S 2453 Ensuring the Value of the 340B Program Act of 2018 Monitored H.R.4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes
- Discussions involving nominations to federally authorized commissions Monitored HR 1130 Fair Medicare Hospital Payments Act of 2017 Monitored S 397 Fair Medicare Hospital Payments Act of 2017 Monitored S 41 Medicare Prescription Drug Price Negotiation Act of 2017 Monitored HR 242 Medicare Prescription Drug Price Negotiation Act of 2017
- Discussions pertinent to health care group purchasing organizations (GPOs) role in helping to prevent drug shortages Monitored HR 277 American Health Care Reform Act of 2017 Monitored S 297 Increasing Competition in Pharmaceuticals Act Monitored HR 749 Lower Drug Costs through Competition Act Monitored HR 208 Ensuring Health Care Opportunities Act Monitored S 1115 Making Pharmaceutical Markets More Competitive Act Monitored HR 2562 Making Pharmaceutical Markets More Competitive Act Monitored S 191 Patient Freedom Act of 2017 Monitored S 761 Health Care Options Act of 2017 Monitored HR 1933 Health Care Options Act of 2017 Monitored HR 1628 American Health Care Act of 2017 Monitored Bipartisan Health Care Stabilization Act 2018 (proposed Alexander-Murray legislation) Monitored S 2312 Helping Ensure Low-income Patients have Access to Care and Treatment (HELP) Act Monitored politically appointed Senate-confirmed positions Monitored S 3158 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 Monitored HR 4191 HHS Cybersecurity Modernization Act Monitored HR 4710 340B PAUSE Act Monitored S 2453 Ensuring the Value of the 340B Program Act of 2018 Monitored H.R.4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes Monitored HR 6 SUPPORT for Patients and Communities Act
- Discussions involving nominations to federally authorized commissions HR 676 Expanded & Improved Medicare for All Act (all sections of full text) HR 1156 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) S 1133 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) Monitored Protecting Patients from Surprise Medical Bills Act (proposed legislation) Monitored HR 1130 Fair Medicare Hospital Payments Act of 2017 Monitored S 397 Fair Medicare Hospital Payments Act of 2017 Monitored S 41 Medicare Prescription Drug Price Negotiation Act of 2017 Monitored HR 242 Medicare Prescription Drug Price Negotiation Act of 2017
- HR 3502 Protecting People From Surprise Medical Bills Act (all sections of full text)(support) S 1266 Protecting Patients from Surprise Medical Bills Act (all sections of full text)(support) S 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (all sections of full text)(support) S 1895 Lower Health Care Costs Act, Title I (all sections of full text)(oppose) S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 3 Lower Drug Costs Now Act of 2019 Monitored HR 3062 Patient Access to Higher Quality Health Care Act of 2019 Monitored HR 861 The End Surprise Billing Act of 2019 Monitored HR 3630 No Surprises Act Monitored implementation of Sec. 6001 of the Affordable Care Act of 2010 Monitored discussions pertinent to health care group purchasing organizations (GPOs) role in helping to prevent drug shortages Monitored Executive Order #13877 Improving Price Quality Transparency in American Healthcare To Put Patients First Monitored HR 4379 Under Performing Directories that Affect Treating Emergencies Act Monitored HR 1897 MOMMA's Act ("Mothers and Offspring Mortality and Morbidity Awareness Act") Monitored HR 1551 Quality Care for Moms and Babies Act Monitored HR 2902 Maternal Care Access and Reducing Emergencies Act Monitored HR 2602 Healthy MOMMIES Act Monitored S 2408 Telehealth Across State Lines Act of 2019
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.